Abridge
Ambient AI platform for clinical documentation with provenance and clinician review workflows.
Last updated: June 5, 2026
Back to directoryAI ambient scribe and medical dictation platform with privacy and security materials for U.S. and Canadian clinical workflows.
Clinicians comparing self-serve or organization-managed scribe tools where HIPAA, PHIPA, SOC 2, and data-residency questions are part of procurement.
Compare within workflow: Clinical documentation and scribes · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Tali AI as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat Tali as draft documentation and dictation support unless a deployment adds clinical advice, coding automation, or patient-facing use that changes review obligations. |
|---|---|
| Privacy | Review the exact regional product terms for audio deletion, transcript retention, data residency, BAA or data-processing agreement coverage, subprocessors, and model-training restrictions. |
| Evidence | Validate note accuracy, specialty terminology, hallucinated facts, missing negatives, and template fit on local encounters before using generated notes at scale. |
| Workflow | Best governed as a clinician-controlled scribe with recording consent, draft status, final signoff, EHR insertion checks, and documented correction tracking. |
Tali describes an AI Ambient Scribe and AI Medical Dictation product, with public pricing, FAQ, privacy, and security materials that discuss HIPAA, PHIPA, SOC 2 Type II, data residency options, audio handling, and clinician documentation workflows.
Not for: Final clinical documentation without clinician review, unsupported EHR workflows, or deployments without patient-consent and recording policies.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.